These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1395956)

  • 41. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus.
    Kafatos G; Anastassopoulou C; Nardone A; Andrews N; Barbara C; Boot HJ; Butur D; Davidkin I; Gelb D; Griskevicius A; Hesketh L; Icardi G; Jones L; Kra-Oz Z; Miller E; Mossong J; Nemecek V; de Ory F; Sobotová Z; Thierfelder W; Van Damme P; Hatzakis A
    J Viral Hepat; 2007 Apr; 14(4):260-8. PubMed ID: 17381718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Inappropriately ordered tests from hepatitis B vaccinated subjects].
    Ozbek OA; Oktem IM
    Mikrobiyol Bul; 2010 Apr; 44(2):285-90. PubMed ID: 20549964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A cost-benefit analysis of blood donor vaccination as an alternative to additional DNA testing for reducing transfusion transmission of hepatitis B virus.
    Fischinger JM; Stephan B; Wasserscheid K; Eichler H; Gärtner BC
    Vaccine; 2010 Nov; 28(49):7797-802. PubMed ID: 20875488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients.
    Oddone EZ; Cowper PA; Hamilton JD; Feussner JR
    Health Serv Res; 1993 Apr; 28(1):97-121. PubMed ID: 8463111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of hepatitis B serology testing before hepatitis B vaccination in the Akha tribal children in northeastern Thailand.
    Custodio H; Mirza A; Salahuddin A; Ferguson K; Rathore M
    Pediatr Infect Dis J; 2011 Aug; 30(8):725. PubMed ID: 21750450
    [No Abstract]   [Full Text] [Related]  

  • 47. Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity.
    Ginsberg GM; Berger S; Shouval D
    Bull World Health Organ; 1992; 70(6):757-67. PubMed ID: 1486673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HBV pre-vaccination screening in hospital personnel: cost-effectiveness analysis.
    Corrao G; Zotti C; Tinivella F; Moiraghi Ruggenini A
    Eur J Epidemiol; 1987 Mar; 3(1):25-9. PubMed ID: 3108025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of anti-HBc in anti-HBs positive individuals: implications for selecting vaccine candidates.
    Hanson M; Polesky HF
    Am J Clin Pathol; 1984 Dec; 82(6):716-9. PubMed ID: 6239539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Decision tree and cost-benefit analysis on strategies related to preventing maternal-infantile transmission of hepatitis B virus infection].
    Shi G; Zhang SX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Mar; 34(3):273-8. PubMed ID: 23759236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B immunity in hospital staff targeted for vaccination. Role of screening tests in immunization programs.
    Grady GF
    JAMA; 1982 Nov; 248(18):2266-9. PubMed ID: 7131678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A cost-effectiveness analysis of prevaccination testing for hepatitis B in adolescents and preadolescents.
    Kwan-Gett TS; Whitaker RC; Kemper KJ
    Arch Pediatr Adolesc Med; 1994 Sep; 148(9):915-20. PubMed ID: 8075733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An economic analysis of premarriage prevention of hepatitis B transmission in Iran.
    Adibi P; Rezailashkajani M; Roshandel D; Behrouz N; Ansari S; Somi MH; Shahraz S; Zali MR
    BMC Infect Dis; 2004 Sep; 4():31. PubMed ID: 15347430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of HBsAg pulsed dendritic vaccination on anti-HBs production in immunosuppressed rats after liver transplantation].
    Li Y; Chen XF; Liu ZJ; Gong JP; Li SW
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):32-6. PubMed ID: 20128966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.
    Bloom BS; Hillman AL; Fendrick AM; Schwartz JS
    Ann Intern Med; 1993 Feb; 118(4):298-306. PubMed ID: 8420448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of methods of pre-vaccination screening for markers of hepatitis B infection.
    Papaevangelou G; Roumeliotou-Karayannis A; Tassopoulos N; Richardson SC; Stathopoulou P; Papadoyannakis N; Tsantoulis N; Politi K; Tassiopoulou A
    Eur J Epidemiol; 1985 Jun; 1(2):100-3. PubMed ID: 2946600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Universal hepatitis B vaccination: the economics of prevention.
    Krahn MD; Detsky AS
    CMAJ; 1992 Jan; 146(1):19-21. PubMed ID: 1530815
    [No Abstract]   [Full Text] [Related]  

  • 58. Cost-effectiveness of ensuring hepatitis B protection for previously vaccinated healthcare personnel.
    Hoerger TJ; Bradley C; Schillie SF; Reilly M; Murphy TV
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):845-54. PubMed ID: 24915213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost effectiveness of hepatitis B vaccine.
    Seligman SJ
    N Engl J Med; 1983 Jan; 308(2):104-5. PubMed ID: 6401194
    [No Abstract]   [Full Text] [Related]  

  • 60. Hepatitis B: old virus, new problems?
    Barbara JA
    Vox Sang; 1994; 67 Suppl 3():239-42. PubMed ID: 7975500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.